Detalles de la búsqueda
1.
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
Eur J Neurol
; 30(1): 224-234, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36097739
2.
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study.
J Headache Pain
; 24(1): 30, 2023 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949388
Resultados
1 -
2
de 2
1
Próxima >
>>